Event Details
Crinetics management will discuss the preliminary findings from the single ascending dose cohorts from the Phase 1 clinical study of CRN04777 that were reported today.
News & Events
Crinetics Reviews CRN04777 Phase 1 Single-ascending Dose Results
Transforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
